Compliance Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026.

ROSSARI · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+4.2%1-day move

₹426.90

prior close

₹428.10

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+3.5+3.6+2.2+1.7+4.2+6.1+5.4+6.6+5.2+12.7+10.1+15.0+19.2+24.9

Up moveDown movePending

AI summary

Rossari Biotech has filed its quarterly compliance certificate for Q4 ended March 31, 2026, confirming that its Registrar and Share Transfer Agent, MUFG Intime India Private Limited, processed all dematerialisation requests for share certificates received during the quarter. The RTA confirmed that all securities were either accepted or rejected and reported to depositories, and share certificates were mutilated and cancelled after verification. No re-materialisation (remat) requests were received during the quarter. This is a routine regulatory filing under SEBI (Depositories and Participants) Regulations, 2018.

Likely market impact

This is a standard regulatory compliance filing with no direct impact on stock price or shareholder value. It confirms the company is in good standing with SEBI depository requirements for the quarter.